Literature DB >> 18770812

Comparative overview of flow and image cytometry.

J Paul Robinson1.   

Abstract

This unit considers the issues of which tool to use--flow cytometry or imaging--and under what conditions. In particular, it compares the advantages and disadvantages of flow and image cytometry and provides examples illustrating the proper choice of each technology. The result is a better understanding of why the two technologies are complementary in many applications. It is clear that many scientists use the tools that are familiar to them, often in preference to the best tool. In cases where very advanced and rather expensive technologies are concerned, this is not surprising. However, there are clearly times when one form of cytometry is definitely superior to another. What then constitute the criteria for a decision when both flow cytometry and imaging are available? This unit addresses some of these concerns.

Mesh:

Substances:

Year:  2005        PMID: 18770812     DOI: 10.1002/0471142956.cy1201s31

Source DB:  PubMed          Journal:  Curr Protoc Cytom        ISSN: 1934-9297


  4 in total

1.  Preparing Viable Single Cells from Human Tissue and Tumors for Cytomic Analysis.

Authors:  Nalin Leelatian; Deon B Doxie; Allison R Greenplate; Justine Sinnaeve; Rebecca A Ihrie; Jonathan M Irish
Journal:  Curr Protoc Mol Biol       Date:  2017-04-03

2.  Robust microbial cell segmentation by optical-phase thresholding with minimal processing requirements.

Authors:  H Alanazi; A J Canul; A Garman; J Quimby; A E Vasdekis
Journal:  Cytometry A       Date:  2017-03-30       Impact factor: 4.355

Review 3.  Technical challenges in the isolation and analysis of circulating tumor cells.

Authors:  Emma E van der Toom; James E Verdone; Michael A Gorin; Kenneth J Pienta
Journal:  Oncotarget       Date:  2016-09-20

Review 4.  Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors.

Authors:  Lara Gibellini; Sara De Biasi; Camillo Porta; Domenico Lo Tartaro; Roberta Depenni; Giovanni Pellacani; Roberto Sabbatini; Andrea Cossarizza
Journal:  Front Immunol       Date:  2020-03-20       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.